Status:
UNKNOWN
Effectiveness of Prehabilitation for Patients Undergoing Lumbar Spinal Stenosis Surgery
Lead Sponsor:
The Hong Kong Polytechnic University
Collaborating Sponsors:
Université du Québec à Trois-Rivières
The University of Hong Kong
Conditions:
Lumbar Spinal Stenosis
Prehabilitation
Eligibility:
All Genders
50+ years
Phase:
NA
Brief Summary
Lumbar spinal stenosis (LSS) is a common spinal disease that leads to pain and disability. LSS is defined as lower extremity and perineal symptoms (e.g. intermittent neurogenic claudication/numbness) ...
Detailed Description
Lumbar spinal stenosis (LSS) is a common spinal disease that leads to pain and disability. LSS is defined as lower extremity and perineal symptoms (e.g. intermittent neurogenic claudication/numbness) ...
Eligibility Criteria
Inclusion
- signs of neurogenic claudication
- radiological signs of degenerative LSS on magnetic resonance images or computed tomography images
- radiculopathy with or without low back pain for more than 3 months that is unresponsive to conservative intervention
- Oswestry Disability Index (ODI) \> 30 out of 100
- patients undergoing open or minimally invasive laminotomy/laminectomy
- willing to complete pre- and post-operative questionnaires and physical assessments at prescheduled time points
Exclusion
- inability to read, speak and understand English/Chinese
- inability to give informed consent
- surgical management for lumbar fractures, tumors, synovial cysts, and scoliosis correction
- any revision lumbar spine surgery, (5) diagnosis of chronic pain conditions (e.g. fibromyalgia)
- presence of a neurological or systematic neuromuscular diseases (e.g. multiple sclerosis, stroke, or rheumatoid arthritis)
- planning for spinal fusion
- discogenic nerve compression or instability (flexion-extension X-ray film shows \> 5mm of sagittal-plane translation)
Key Trial Info
Start Date :
August 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2022
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03388983
Start Date
August 10 2018
End Date
June 30 2022
Last Update
February 10 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Queen Mary Hospital
Hong Kong, Hong Kong